David Barda is a seasoned professional with extensive experience in various leadership roles within the biomedical and technology sectors. Notable positions include Director at Solvanix Pty Ltd and G2 Therapies Pty Limited, Business Development Advisor at National Computational Infrastructure, and Principal and Founder of D4 Bioventures. Additional roles encompass Vice President of the Biomedical Sciences Division at Exploit Technologies Pte Ltd, Founder and CEO at Fred Bergman Healthcare, and various advisory positions in commercialization and innovation across multiple organizations. Barda also holds a Master of Law from Monash University and a Bachelor of Science from UNSW, demonstrating a strong educational background. Currently, Barda serves as Director of Stakeholder Engagement for the NSW IGP Program at MTPConnect and Founding Executive Director at Sequins.
This person is not in the org chart
This person is not in any teams
This person is not in any offices